{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:50:25Z","timestamp":1788486625533,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T00:00:00Z","timestamp":1516665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Sheikh Hamdan Award for Medical Sciences for Providing Funds for this Work","award":["MRG13\/2005"],"award-info":[{"award-number":["MRG13\/2005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s11010-018-3285-0","type":"journal-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T07:03:11Z","timestamp":1516690991000},"page":"185-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ameliorative effects of supplemental folinic acid on Lamotrigine-induced fetal malformations in the mouse"],"prefix":"10.1007","volume":"446","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5853-6578","authenticated-orcid":false,"given":"Y. M.","family":"Abdulrazzaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Shafiullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kochyil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4771-7140","authenticated-orcid":false,"given":"S. M. A.","family":"Bastaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,23]]},"reference":[{"issue":"8","key":"3285_CR1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/bdra.23028","volume":"94","author":"LB Holmes","year":"2012","unstructured":"Holmes LB, Hernandez-Diaz S (2012) Newer anticonvulsants: LTG, topiramate and gabapentin. Birth Defects Res A 94(8):599\u2013606","journal-title":"Birth Defects Res A"},{"issue":"7","key":"3285_CR2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","volume":"10","author":"T Tomson","year":"2011","unstructured":"Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A, Perucca E, Vajda F (2011) Dose-dependent risk of malformations with anti-epileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 10(7):609\u2013617","journal-title":"Lancet Neurol"},{"issue":"2","key":"3285_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1535-7597.2002.00017.x","volume":"2","author":"MJ Morrell","year":"2002","unstructured":"Morrell MJ (2002) Folic acid and epilepsy. Epilepsy Curr 2(2):31\u201334","journal-title":"Epilepsy Curr"},{"issue":"2","key":"3285_CR4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ana.22229","volume":"69","author":"M Linnebank","year":"2011","unstructured":"Linnebank M, Moskau S, Semmier A, Widman G, Stoffel-Wagner B, Weller M, Elger CE (2011) Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann Neurol 69(2):352\u2013359","journal-title":"Ann Neurol"},{"issue":"12","key":"3285_CR5","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1007\/s00415-008-0029-1","volume":"255","author":"S Pittschieler","year":"2008","unstructured":"Pittschieler S, Brezinka C, Jahn B, Trinka E, Unterberger I, Dobesberger J, Walser G, Auckenthaler A, Embacher N, Bauer G, Luef G (2008) Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy. J Neurol 255(12):1926\u20131931","journal-title":"J Neurol"},{"issue":"Pt 2","key":"3285_CR6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/brain\/awq352","volume":"134","author":"KJ Meador","year":"2011","unstructured":"Meador KJ, Baker GA, Browning N, Cohen MJ, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW, NEAD Study Group (2011) Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain 134(Pt 2): 396\u2013404","journal-title":"Brain"},{"issue":"Suppl 4","key":"3285_CR7","first-page":"S19-S28","volume":"35","author":"D Lindhout","year":"1994","unstructured":"Lindhout D, Omtzigt JGC (1994) Teratogenic effects of antiepileptic drugs: Implications for the management of epilepsy in women of childbearing age. Epilepsia 35(Suppl 4):S19-S28","journal-title":"Epilepsia"},{"issue":"4","key":"3285_CR8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1212\/01.WNL.0000044157.28073.DC","volume":"60","author":"E Kaaja","year":"2003","unstructured":"Kaaja E, Kaaja R, Hiilesmaa V (2003) Major malformations in offspring of women with epilepsy. Neurology 60(4):575\u2013579","journal-title":"Neurology"},{"key":"3285_CR9","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1212\/01.WNL.0000154515.94346.89","volume":"64","author":"M Cunnington","year":"2005","unstructured":"Cunnington M, Tennis P (2005) LTG and the risk of malformations in pregnancy. Neurology 64:955\u2013960","journal-title":"Neurology"},{"issue":"1","key":"3285_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","volume":"28","author":"A Ornoy","year":"2009","unstructured":"Ornoy A (2009) Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reprod Toxicol 28(1):1\u201310","journal-title":"Reprod Toxicol"},{"issue":"1","key":"3285_CR11","first-page":"57","volume":"19","author":"FJ Vajda","year":"2012","unstructured":"Vajda FJ, Graham J, Roten A, Lander CM, O\u2019Brien TJ, Eadie M (2012) Teratogenicity of the newer antiepileptic drugs-the Australian experience. J Clin Sci 19(1):57\u201359","journal-title":"J Clin Sci"},{"issue":"3","key":"3285_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12325-009-0011-z","volume":"26","author":"HT Nguyen","year":"2009","unstructured":"Nguyen HT, Sharma V, McIntyre RS (2009) Teratogenesis associated with antibipolar agents. Adv Ther 26(3):281\u2013294","journal-title":"Adv Ther"},{"issue":"6","key":"3285_CR13","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1586\/ern.10.57","volume":"10","author":"DS Hill","year":"2010","unstructured":"Hill DS, Wlodarczyk BJ, Palacios AM, Finnell RH (2010) Teratogenic effects of antiepileptic drugs. Expert Rev Neurother 10(6):943\u2013959","journal-title":"Expert Rev Neurother"},{"issue":"12","key":"3285_CR14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1055\/s-0029-1246171","volume":"72","author":"C Wild","year":"2010","unstructured":"Wild C, Lehner P, Reiselhuber S, Schiller-Fr\u00fchwirth I (2010) Prevention of neural tube defects: regional policies in folic acid enrichment and supplementation. Gesundheitswesen 72(12):875\u2013879","journal-title":"Gesundheitswesen"},{"issue":"46","key":"3285_CR15","first-page":"2561","volume":"149","author":"WM Meijer","year":"2005","unstructured":"Meijer WM, de Walle HE (2005) Differences in folic-acid policy and the prevalence of neural-tube defects in Europe; recommendations for food fortification in a EUROCAT report. Ned Tijdschr Geneeskd 149(46):2561\u20132564","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"11","key":"3285_CR16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1701-2163(16)30248-1","volume":"25","author":"RD Wilson","year":"2003","unstructured":"Wilson RD, Davies G, D\u00e9silets V, Reid GJ, Summers A, Wyatt P, Young D (2003) The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 25(11):959\u2013965","journal-title":"J Obstet Gynaecol Can"},{"key":"3285_CR17","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/bdrb.10042","volume":"68","author":"R Padmanabhan","year":"2003","unstructured":"Padmanabhan R, Abdulrazzaq YM, Bastaki SM, Shafiullah M, Chandranath SI (2003) Experimental studies on reproductive toxicologic effects of LTG in mice. Birth Defects Res B 68:428\u2013438","journal-title":"Birth Defects Res B"},{"issue":"1","key":"3285_CR18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1741-4520.2003.tb01024.x","volume":"43","author":"R Padmanabhan","year":"2003","unstructured":"Padmanabhan R, Shafiullah MM (2003) Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation. Congenit Anom 43(1):29\u201340","journal-title":"Congenit Anom"},{"key":"3285_CR19","first-page":"441","volume":"17","author":"A Quattrini","year":"1996","unstructured":"Quattrini A, Ortenzi A, Paggi A et al (1996) LTG and pregnancy [Letter]. Ital J Neurosci 17:441","journal-title":"Ital J Neurosci"},{"key":"3285_CR20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s002280050234","volume":"51","author":"B Rambeck","year":"1997","unstructured":"Rambeck B, Kurlemann G, Stodieck SRG et al (1997) Concentrations of LTG in a mother on LTG treatment and her newborn child. Eur J Clin Pharmacol 51:481\u2013484","journal-title":"Eur J Clin Pharmacol"},{"key":"3285_CR21","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1528-1157.1997.tb01489.x","volume":"38","author":"T Tomson","year":"1997","unstructured":"Tomson T, \u00d6hman I, Vitols S (1997) LTG in pregnancy and lactation: a case report. Epilepsia 38:1039\u20131041","journal-title":"Epilepsia"},{"key":"3285_CR22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/(SICI)1096-9926(199703)55:3<165::AID-TERA1>3.0.CO;2-1","volume":"55","author":"YM Abdulrazzaq","year":"1997","unstructured":"Abdulrazzaq YM, Bastaki SMA, Padmanabhan R (1997) Teratogenic effects of vigabatrin in the TO mouse fetuses. Teratology 55:165\u2013176","journal-title":"Teratology"},{"key":"3285_CR23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/tera.1023","volume":"63","author":"YM Abdulrazzaq","year":"2001","unstructured":"Abdulrazzaq YM, Padmanabhan R, Bastaki SMA, Ibrahim A, Bener A (2001) Placental transfer of vigabatrin (\u03b3-vinyl GABA) and its effect on concentrations of amino acids in the embryo of TO mice. Teratology 63:127\u2013133","journal-title":"Teratology"},{"issue":"8","key":"3285_CR24","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1515\/cclm-2014-0843","volume":"53","author":"E \u0130spir","year":"2015","unstructured":"\u0130spir E, Serdar MA, Ozgurtas T, Gulbahar O, Ak\u0131n KO, Yesildal F, Kurt \u0130 (2015) Comparison of four automated serum vitamin B12 assays. Clin Chem Lab Med 53(8):1205\u20131213","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"3285_CR25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.reprotox.2010.02.005","volume":"29","author":"R Padmanabhan","year":"2010","unstructured":"Padmanabhan R, Abdulrazzaq YM, Bastaki SM, Nurulain M, Shafiullah M (2010) Vigabatrin (VGB) administered during late gestation lowers maternal folate concentration and causes pregnancy loss, fetal growth restriction and skeletal hypoplasia in the mouse. Reprod Toxicol 29(3):366\u2013377","journal-title":"Reprod Toxicol"},{"issue":"6","key":"3285_CR26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00394-006-0600-4","volume":"45","author":"R Padmanabhan","year":"2006","unstructured":"Padmanabhan R, Shafiullah M, Benedict S, Nagelkerke N (2006) Effect of maternal exposure to homocysteine on sodium valproate-induced neural tube defects in the mouse embryos. Eur J Nutr 45(6):311\u2013319","journal-title":"Eur J Nutr"},{"key":"3285_CR27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/tcm.1770050505","volume":"5","author":"H Sterz","year":"1985","unstructured":"Sterz H, Lehmann H (1985) A critical comparison of the free hand razor blade dissection method according to Wilson with an in situ sectioning method for rat fetuses. Terat Carcin Mutagen 5:347\u2013354","journal-title":"Terat Carcin Mutagen"},{"key":"3285_CR28","first-page":"71","volume":"16","author":"M Inouye","year":"1976","unstructured":"Inouye M (1976) Differential staining of cartilage and bone in fetal mouse skeleton by alcian blue and alizarin red S. Congenit Anom 16:71\u2013173","journal-title":"Congenit Anom"},{"key":"3285_CR29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1590\/S0004-282X2001000300010","volume":"59","author":"NS Marchi","year":"2001","unstructured":"Marchi NS, Azoubel R, Tognola WA (2001) Teratogenic effects of LTG on rat fetal brain: a morphometric study. Arq Neuropsiquiatr 59:362\u2013364","journal-title":"Arq Neuropsiquiatr"},{"issue":"6","key":"3285_CR30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1528-1157.2000.tb00232.x","volume":"41","author":"I Ohman","year":"2000","unstructured":"Ohman I, Vitols S, Tomson T (2000) LTG in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 41(6):709\u2013713","journal-title":"Epilepsia"},{"key":"3285_CR31","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJM199804163381607","volume":"338","author":"G Koren","year":"1998","unstructured":"Koren G, Pastuszak A, Ito S (1998) Drugs in pregnancy. N Engl J Med 338:1128\u20131137","journal-title":"N Engl J Med"},{"key":"3285_CR32","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/humupd\/dmp052","volume":"16","author":"MM Gelder van","year":"2010","unstructured":"van Gelder MM, van Rooij IA, Miller RK, Zielhuis GA, de Jong-van den Berg LT, Roeleveld N (2010) Teratogenic mechanisms of medical drugs. Hum Reprod Update 16:378\u2013394","journal-title":"Hum Reprod Update"},{"key":"3285_CR33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1212\/WNL.42.1.43","volume":"42","author":"D Lindhout","year":"1992","unstructured":"Lindhout D (1992) Pharmacogenetics and drug interactions: Role in antiepileptic-drug-induced teratogenesis. Neurology 42:43\u201347","journal-title":"Neurology"},{"issue":"3","key":"3285_CR34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eplepsyres.2005.06.004","volume":"65","author":"V Petrenaite","year":"2005","unstructured":"Petrenaite V, Sabers A, Hansen-Schwartz J (2005) Individual changes in LTG plasma concentrations during pregnancy. Epilepsy Res 65(3):185\u2013188","journal-title":"Epilepsy Res"},{"issue":"3","key":"3285_CR35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.eplepsyres.2011.02.002","volume":"94","author":"A Reimers","year":"2011","unstructured":"Reimers A, Helde G, Br\u00e5then G, Brodtkorb E (2011) LTG and its N2-glucuronide during pregnancy: the significance of renal clearance and estradiol. Epilepsy Res 94(3):198\u2013205","journal-title":"Epilepsy Res"},{"issue":"2","key":"3285_CR36","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1021\/tx2004536","volume":"25","author":"RJ Tureski","year":"2012","unstructured":"Tureski RJ, Bessette EE, Dunbar D, Liberman RG, Skipper PL (2012) Cytochrome P450-mediated metabolism and DNA binding of 2-Amino-1,7-dimethylimidazo[4,5-g]quinoxaline and its carcinogenic isomer2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline in mice. Chem Res Toxicol 25(2):410\u2013421","journal-title":"Chem Res Toxicol"},{"issue":"6","key":"3285_CR37","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1528-1167.2007.01021.x","volume":"48","author":"M Cunnington","year":"2007","unstructured":"Cunnington M, Ferber S, Quartey G; International Lamotrigine Pregnancy Registry Scientific Advisory Committee (2007) Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study. Epilepsia 48(6):1207\u20131210","journal-title":"Epilepsia"},{"issue":"7","key":"3285_CR38","doi-asserted-by":"publisher","first-page":"e0131130","DOI":"10.1371\/journal.pone.0131130","volume":"10","author":"L Ban","year":"2015","unstructured":"Ban L, Fleming KM, Doyle P, Smeeth L, Hubbard RB, Fiaschi L, Tata LJ (2015) Congenital Anomalies in children of mothers taking antiepileptic drugs with and without periconceptional high dose folic acid use: a population-based cohort study. PLoS ONE 10(7): e0131130. https:\/\/doi.org\/10.1371\/journal.pone.0131130","journal-title":"PLoS ONE"},{"key":"3285_CR39","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.seizure.2010.07.019","volume":"19","author":"FJE Vajda","year":"2010","unstructured":"Vajda FJE, Graham JE, Hitchcock AA, O\u2019Brien TJ, Lander CM, Eadie MJ (2010) Is LTG a significant human teratogen? Observations from the Australian Pregnancy Register. Seizure 19:558\u2013561","journal-title":"Seizure"},{"key":"3285_CR40","first-page":"CD010224","volume":"11","author":"J Weston","year":"2016","unstructured":"Weston J, Bromley R, Jackson CF, Adab N, Clayton-Smith J, Greenhalgh J, Hounsome J, McKay AJ, Tudur Smith C, Marson AG (2016) Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev 11:CD010224","journal-title":"Cochrane Database Syst Rev"},{"key":"3285_CR41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/00325481.1990.11716375","volume":"88","author":"IE Leppik","year":"1990","unstructured":"Leppik IE (1990) How to get patients with epilepsy to take their medication. The problem of noncompliance. Postgrad Med 88:253\u2013256","journal-title":"Postgrad Med"},{"key":"3285_CR42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0404.1984.tb07805.x","volume":"69","author":"J Hendel","year":"1984","unstructured":"Hendel J, Dam M, Gram L, Winkel P, Jorgensen I (1984) The effect of carbamezapine and valproate on folate metabolism in man. Acta Neurol Scand 69:226\u2013231","journal-title":"Acta Neurol Scand"},{"key":"3285_CR43","first-page":"703","volume":"86","author":"PN Kirke","year":"1993","unstructured":"Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM (1993) Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 86:703\u2013708","journal-title":"Q J Med"},{"issue":"11","key":"3285_CR44","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1111\/j.1651-2227.2012.02795.x","volume":"101","author":"Q Gu","year":"2012","unstructured":"Gu Q, Li Y, Cui ZL, Luo XP (2012) Homocysteine, folate, vitamin B12 and B6 in mothers of children with neural tube defects in Xinjiang, China. Acta Paediatr 101(11):e486\u2013e490","journal-title":"Acta Paediatr"},{"key":"3285_CR45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0140-6736(95)90165-5","volume":"345","author":"JL Mills","year":"1995","unstructured":"Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM (1995) Homocysteine metabolism in pregnancies complicated by neural tube defects. Lancet 345:149\u2013151","journal-title":"Lancet"},{"key":"3285_CR46","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00007611-200194030-00007","volume":"94","author":"MM Iqbal","year":"2001","unstructured":"Iqbal MM, Gundlapalli SP, Ryan WG, Ryals T, Passman TE (2001) Effect of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants. South Med J 94:304","journal-title":"South Med J"},{"key":"3285_CR47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/tera.1420150110","volume":"15","author":"RL Jordan","year":"1977","unstructured":"Jordan RL, Wilson JG, Schumacher HJ (1977) Embryotoxicity of the folate antagonist methotrexate in rats and rabbits. Teratology 15:73\u201380","journal-title":"Teratology"},{"key":"3285_CR48","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1176\/appi.ajp.2012.11071114","volume":"169","author":"GI Papakostas","year":"2012","unstructured":"Papakostas GI, Shelton RC, Zajecka JM et al (2012) L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry 169:1267\u20131274","journal-title":"Am J Psychiatry"},{"key":"3285_CR49","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/0140-6736(92)91207-O","volume":"339","author":"MJ Brodie","year":"1992","unstructured":"Brodie MJ (1992) LTG Lancet 339:1397\u20131400","journal-title":"Lancet"},{"key":"3285_CR50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S2215-0366(15)00450-2","volume":"3","author":"JR Geddes","year":"2016","unstructured":"Geddes JR, Gardiner A, Rendell J, Voysey M, Tunbridge E, Hinds C, Yu L-M, Hainsworth J, Attenburrow M-J, Somin J, Goodwin GM, Harrison PJ, CEQUEL Investigators and Collaborators (2016) Comparative evaluation of quetiapine plus LTG combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 \u00d7 2 factorial randomised trial. Lancet Psychiatry 3:31\u201339","journal-title":"Lancet Psychiatry"},{"key":"3285_CR51","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/WNL.0000000000002540","volume":"86","author":"H Dolk","year":"2016","unstructured":"Dolk H, Wang H, Loane M, Morris J, Garne E, Addor M-C et al (2016) LTG use in pregnancy and risk of orofacial cleft and other congenital anomalies. Neurology 86:1716\u20131725","journal-title":"Neurology"},{"key":"3285_CR52","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0920-1211(00)00150-9","volume":"41","author":"A Verrotti","year":"2000","unstructured":"Verrotti A, Pascarella R, Trotta D, Giuva T, Morgese G, Chiarelli F (2000) Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine. Epilepsy Res 41:253\u2013257","journal-title":"Epilepsy Res"},{"key":"3285_CR53","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/WNL.52.4.750","volume":"52","author":"E Alonso-Aperte","year":"1999","unstructured":"Alonso-Aperte E, Ubeda N, Achon M, Perez-Miguelsanz J, Varela-Moreiras G (1999) Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation. Neurology 52:750\u2013756","journal-title":"Neurology"},{"key":"3285_CR54","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0026-0495(99)90204-4","volume":"48","author":"JH Yoo","year":"1999","unstructured":"Yoo JH, Hong SB (1999) A common mutation in the methylenetetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in epileptic patients receiving anticonvulsants. Metabolism 48:1047\u20131051","journal-title":"Metabolism"},{"key":"3285_CR55","first-page":"1422","volume":"57","author":"R Dias-Arrastia","year":"2000","unstructured":"Dias-Arrastia R (2000) Homocysteine and neurologic disease. Arch Neurol 57:1422\u20131427","journal-title":"Arch Neurol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-018-3285-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-018-3285-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-018-3285-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T12:26:36Z","timestamp":1533126396000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-018-3285-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,23]]},"references-count":55,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["3285"],"URL":"https:\/\/doi.org\/10.1007\/s11010-018-3285-0","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,23]]}}}